Too little is known about the risks of gene drives to responsibly release them in natural environments, say the authors of a new National Academies report.
To avoid missteps with a powerful genetic engineering technology that can modify species, one scientist demands total transparency.
This week’s most interesting and thought-provoking papers from the Physics arXiv.
A startup says its technology can serve as an objective concussion test. The challenge is convincing people it works.
To match cancer patients with drugs, one company plans to offer free genetic tests.
What will scientists do with $100 million to mass-produce genes in the lab?
Another chance to catch the most interesting, and important, articles from the previous week on MIT Technology Review.
Printing genomes on demand could mean custom-built organisms, difficult ethical questions, and profits for a handful of companies.
New approaches to generating crop varieties are making it hard for policymakers to know what to regulate.
Massive gene studies are letting biotechnology companies learn from nature, and imitate it.